Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Singular Health Group Ltd ( (AU:SHG) ) has provided an update.
Singular Health Group Ltd has signed a Memorandum of Understanding (MoU) with Provider Network Solutions (PNS) to pilot and potentially roll out their 3Dicom software across PNS’s network. The agreement marks a significant opportunity for Singular Health to demonstrate the software’s capabilities in improving medical imaging processes. The company also raised AUD$3.7 million to support further software development and implementation of the pilot program. Additionally, Dr. Ronny Low has been appointed as a technical advisor to aid the project’s execution. The collaboration with Edith Cowan University and the Arthritis and Osteoporosis WA Foundation on a Bone and Joint Health Project was successfully completed, underscoring Singular Health’s commitment to medical education and innovation.
More about Singular Health Group Ltd
Singular Health Group Ltd is a medical technology company specializing in developing innovative solutions for medical imaging. Their primary product is the 3Dicom software, which aims to enhance medical imaging workflows by reducing duplicate imaging and improving access across disparate systems. The company focuses on leveraging artificial intelligence to analyze medical data and improve patient care.
YTD Price Performance: 8.89%
Average Trading Volume: 1,409,342
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$62.95M
See more insights into SHG stock on TipRanks’ Stock Analysis page.
